ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

Greenwald: Report’s Implementation Will Require Budget Raise

June 27, 1997

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

In Brief: Kessler Urges Cardiologists To Fight Teen Smoking; ODAC To Meet Dec. 14

December 1, 1995

American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.

November 16, 2001